Somatostatin Analogues
Octreotide · Lanreotide · Pegvisomant
TargetsGH, TSH, glucagon, insulin, gut peptides
Key usesAcromegaly, carcinoid syndrome, VIPoma, variceal bleed
ADRGallstones, steatorrhea, hyperglycemia
TrapPegvisomant blocks the GH receptor, not secretion
The Off Switch for half the endocrine pantry.
tap to flip →
Why It Works
Trace It
Octreotide mimics endogenous somatostatin: binds SST receptors and shuts down secretion of growth hormone, TSH, glucagon, insulin, and a long list of GI peptides such as VIP, serotonin, gastrin, secretin, and motilin.
Uses
Acromegaly: drops GH and IGF-1.
Carcinoid syndrome: blocks serotonin and VIP flood causing flushing and diarrhea.
VIPoma, glucagonoma, gastrinoma.
Esophageal variceal bleed: splanchnic vasoconstriction.
Pegvisomant exception
Used in octreotide-refractory acromegaly. Blocks the peripheral GH receptor itself, so GH levels rise but IGF-1 falls. Different drug, different lane.
Lock It
Surgery patient with flushing, diarrhea, and bronchospasm intraoperatively? Carcinoid crisis. Reach for octreotide. Same drug for acute variceal bleed and refractory secretory diarrhea.